Do we want more cancer patients on clinical trials If so, what are the barriers to greater accrual

Trials

Volumn 9, Issue , 2008, Pages

  Vickers, Andrew J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER RESEARCH; CLINICAL PROTOCOL; DATA COLLECTION METHOD; FINANCIAL MANAGEMENT; HEALTH CARE ORGANIZATION; INFORMATION TECHNOLOGY; INFORMED CONSENT; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; NOTE; PATIENT PARTICIPATION; PATIENT SELECTION; PRACTICE GUIDELINE; SAMPLE SIZE; UNITED STATES;

EID: 45549090542     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-9-31     Document Type: Note

References (13)

1. Wright JR Kowaleski B Sussman J What constitutes a "clinical trial"?: A survey of oncology professionals Trials 2008, 9(1):12. 2267771 18315883 10.1186/1745-6215-9-12
2. Sateren WB Trimble EL Abrams J Brawley O Breen N Ford L McCabe M Kaplan R Smith M Ungerleider R Christian MC How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials J Clin Oncol 2002, 20(8):2109-2117. 10.1200/ JCO.2002.08.056 11956272
3. Bell J Resuscitating clinical research in the United Kingdom BMJ 2003, 327(7422):1041-1043. 261667 14593043 10.1136/bmj.327.7422.1041
4. Duley L Antman K Arena J Avezum A Blumenthal M Bosch J Chrolavicius S Li T Ounpuu S Perez AC Sleight P Svard R Temple R Tsouderous Y Yunis C Yusuf S Specific barriers to the conduct of randomized trials Clin Trials 2008, 5(1):40-48. 10.1177/1740774507087704 18283079
5. Altman DG The scandal of poor medical research BMJ 1994, 308(6924):283-284. 8124111
6. Why so many dead-end phase II trials? http://cancernetwork.com/oni/ showArticle.jhtml?articleId=205200419
7. Vickers AJ Kuo J Cassileth BR Unconventional anticancer agents: A systematic review of clinical trials J Clin Oncol 2006, 24(1):136-140. 1472241 16382123 10.1200/JCO.2005.03.8406
8. Djulbegovic B Kumar A Soares HP Hozo I Bepler G Clarke M Bennett CL Treatment success in cancer: New cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006 Arch Intern Med 2008, 168(6):632-642. 10.1001/archinte.168.6.632 18362256
9. Goldberg K CALGB chairman Schilsky to step down after 15 years leading cooperative group The Cancer Letter 2008, 34:1-4.
10. Dilts DM Sandler AB Baker M Cheng SK George SL Karas KS McGuire S Menon GS Reusch J Sawyer D Scoggins M Wu A Zhou K Schilsky RL Case of Cancer and Leukemia Group B Processes to activate phase III clinical trials in a Cooperative Oncology Group: The Case of Cancer and Leukemia Group B J Clin Oncol 2006, 24(28):4553-4557. 10.1200/JCO.2006.06.7819 17008694
11. Report of the National Cancer Institute Clinical Trials Program Review Group National Cancer Institute 1997.
12. Wilt TJ MacDonald R Rutks I Shamliyan TA Taylor BC Kane RL Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer Ann Intern Med 2008, 148(6):435-448. 18252677
13. Anthes E Allen S US cancer researchers go abroad for trials Boston Globe 2007, December 29th